These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 305488)

  • 1. [Anti-nuclear antibody (author's transl)].
    Okita N; Kodama K; Ito Y; Nakayama J; Yamasaki H
    Rinsho Byori; 1978 Feb; 26(2):110-5. PubMed ID: 305488
    [No Abstract]   [Full Text] [Related]  

  • 2. [Significance of antinuclear antibodies in rheumatology].
    Ciobanu V; Boloşiu HD
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1986; 38(2):97-111. PubMed ID: 2875509
    [No Abstract]   [Full Text] [Related]  

  • 3. Current status of tests for antinuclear antibodies (ANA) in rheumatic diseases.
    Nakamura RN; Tan EM
    West J Med; 1978 Jan; 128(1):51-2. PubMed ID: 415436
    [No Abstract]   [Full Text] [Related]  

  • 4. [C1q solid-phase radioimmunoassay for detection of circulating immune complexes in patients with systemic lupus erythematosus (author's transl)].
    Sato M; Kasukawa R; Suzuki S; Kameda S; Yoshida T
    Ryumachi; 1978 Mar; 18(2):97-103. PubMed ID: 307277
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antibodies to denatured DNA detected by millipore filter assay in patients with SLE and other rheumatic diseases (author's transl)].
    Sarai T; Miyawaki S; Kurata N; Ofuji T
    Ryumachi; 1978 Sep; 18(5):335-43. PubMed ID: 310165
    [No Abstract]   [Full Text] [Related]  

  • 6. [Laboratory findings in rheumatic diseases (author's transl)].
    Hohmeister R
    Schweiz Rundsch Med Prax; 1979 Mar; 68(10):326-30. PubMed ID: 311471
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibody to extractable nuclear antigen in the rheumatic diseases.
    McCain GA; Bell DA; Chodirker WB; Komar RR
    J Rheumatol; 1978; 5(4):399-406. PubMed ID: 310883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The meaning of antinuclear antibodies and of the ASL O titer in rheumatic diseases (author's transl)].
    Zirm M
    Klin Monbl Augenheilkd; 1979 Jan; 174(1):82-7. PubMed ID: 311873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guidelines for immunologic laboratory testing in the rheumatic diseases: anti-DNA antibody tests.
    Kavanaugh AF; Solomon DH;
    Arthritis Rheum; 2002 Oct; 47(5):546-55. PubMed ID: 12382306
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification of a new antinuclear antibody by immunoblotting.
    de Keyser F; Verbruggen G; Veys EM
    Lancet; 1989 Oct; 2(8668):927. PubMed ID: 2571852
    [No Abstract]   [Full Text] [Related]  

  • 11. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
    Salonen EM; Miettinen A; Walle TK; Koskenmies S; Kere J; Julkunen H
    Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Determination of antinuclear antibodies in rheumatic diseases].
    Endresen GK; Mellbye OJ
    Tidsskr Nor Laegeforen; 1991 Feb; 111(6):716-9. PubMed ID: 2008695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical significance of determining anti-extractable nuclear antigen in subjects with immunofluorecent negative anti-nuclear antibodies].
    Sakai H; Katayama Y; Haranou Y
    Rinsho Byori; 1989 Feb; 37(2):159-63. PubMed ID: 2499708
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevalence of anti-SSA (Ro) antibodies in a Mexican population of patients with various systemic rheumatic diseases.
    García-de la Torre I; Sánchez-Guerrero A; Salmón-de la Torre G; Hernández-Vázquez L
    J Rheumatol; 1987 Jun; 14(3):479-81. PubMed ID: 3498034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relationship of renal histopathology to immunoglobulin classes and complement fixation of anti-native DNA antibodies and components of immune complexes in patients with systemic lupus erythematosus (author's transl)].
    Hashimoto H; Utagawa Y; Yamagata J; Okada T; Shiokawa Y; Suzuki S; Tomiyama T
    Ryumachi; 1981 Sep; 21(5):366-74. PubMed ID: 6977194
    [No Abstract]   [Full Text] [Related]  

  • 16. [Diagnosis of rheumatologic diseases. Significance of autoantibodies against nuclear antigens].
    Poralla T; Mayet W; Hermann E; Manns M; Meyer zum Büschenfelde KH
    Fortschr Med; 1988 Dec; 106(36):726-9. PubMed ID: 3069672
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antibodies against soluble nuclear antigens in rheumatic diseases].
    Nikolov K; Baleva M
    Vutr Boles; 1987; 26(5):112-7. PubMed ID: 3324484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antinuclear antibodies in the investigation of rheumatic diseases.
    Fritzler MJ
    Bull Rheum Dis; 1985; 35(6):1-10. PubMed ID: 3879803
    [No Abstract]   [Full Text] [Related]  

  • 19. [Rheumatologic symptoms with medicament intolerance (author's transl)].
    Jungo O
    Schweiz Rundsch Med Prax; 1978 Aug; 67(32):1175-7. PubMed ID: 307758
    [No Abstract]   [Full Text] [Related]  

  • 20. [Lupus nephropathy with mesangial expansion. Possible association with the anti Sm antibody (author's transl)].
    Reyes PA; Salinas-Madrigal L
    Rev Invest Clin; 1980; 32(2):199-204. PubMed ID: 6968446
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.